Yoh Matsumoto Selected Research

Therapeutics

12/2013	Minocycline suppresses experimental autoimmune encephalomyelitis by increasing tissue inhibitors of metalloproteinases.
9/2012	Characterization of fibrosis-promoting factors and siRNA-mediated therapies in C-protein-induced experimental autoimmune myocarditis.
8/2011	Intravenous immunoglobulin therapy prevents development of autoimmune encephalomyelitis and suppresses activation of matrix metalloproteinases.
4/2008	DNA vaccine therapy for Alzheimer's disease: present status and future direction.
7/2007	Development of anti-Abeta vaccination as a promising therapy for Alzheimer's disease.
6/2006	Nonviral Abeta DNA vaccine therapy against Alzheimer's disease: long-term effects and safety.
3/2005	New approach to immunotherapy against organ-specific autoimmune diseases with T cell receptor and chemokine receptor DNA vaccines.
6/2003	Characterization of the antigen specificity and TCR repertoire, and TCR-based DNA vaccine therapy in myelin basic protein-induced autoimmune encephalomyelitis in DA rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoh Matsumoto Research Topics

Disease

19	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 12/2013 - 05/2002
11	Multiple Sclerosis 02/2013 - 05/2003
9	Inflammation (Inflammations) 02/2013 - 03/2005
9	Autoimmune Diseases (Autoimmune Disease) 04/2009 - 05/2002
8	Alzheimer Disease (Alzheimer's Disease) 01/2015 - 06/2006
8	Myocarditis (Carditis) 09/2012 - 02/2004
8	Experimental Autoimmune Neuritis 06/2010 - 11/2004
7	Encephalomyelitis (Myeloencephalitis) 08/2011 - 05/2002
5	Demyelinating Diseases (Demyelinating Disease) 02/2013 - 10/2004
4	Disease Progression 01/2013 - 09/2004
4	Neuromyelitis Optica (Devic's Disease) 10/2009 - 10/2004
3	Neuroinflammatory Diseases 12/2013 - 06/2006
3	Myositis (Idiopathic Inflammatory Myopathies) 10/2010 - 04/2007
3	Paralysis (Palsy) 06/2010 - 02/2005
3	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 10/2009 - 09/2004
2	Fibrosis (Cirrhosis) 09/2012 - 01/2007
2	Optic Neuritis (Retrobulbar Neuritis) 04/2011 - 10/2009
2	Polymyositis 10/2010 - 10/2007
2	Retinal Degeneration 11/2009 - 05/2008
2	Experimental Nervous System Autoimmune Disease 10/2007 - 09/2007
1	Low Tension Glaucoma 11/2009
1	Meningoencephalitis 06/2009
1	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2008
1	Brain Injuries (Brain Injury) 05/2008
1	Ischemia 05/2008
1	Wounds and Injuries (Trauma) 05/2008
1	Body Weight (Weight, Body) 12/2007
1	Blindness (Hysterical Blindness) 01/2007
1	Leukocytosis (Pleocytosis) 01/2007
1	Chronic Progressive Multiple Sclerosis 08/2006
1	Myasthenia Gravis 04/2006
1	Colorectal Neoplasms (Colorectal Cancer) 03/2006
1	Neuritis (Polyneuritis) 04/2005

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 09/2012 - 09/2004
7	DNA VaccinesIBA 01/2013 - 06/2003
6	Peptides (Polypeptides)IBA 01/2013 - 06/2006
5	Myelin-Oligodendrocyte GlycoproteinIBA 04/2011 - 10/2004
5	Caveolin 1IBA 03/2007 - 08/2005
5	Complementarity Determining Regions (Complementarity Determining Region)IBA 11/2006 - 05/2002
4	AntibodiesIBA 04/2011 - 04/2007
4	ChemokinesIBA 01/2010 - 09/2004
4	DNA (Deoxyribonucleic Acid)IBA 06/2009 - 05/2002
4	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2006 - 05/2002
4	Myelin Basic ProteinIBA 08/2006 - 03/2003
3	Matrix Metalloproteinases (MMPs)IBA 12/2013 - 10/2009
3	CytokinesIBA 01/2013 - 01/2010
3	AutoantibodiesIBA 04/2011 - 10/2007
3	Chemokine ReceptorsIBA 08/2006 - 09/2004
3	AntigensIBA 03/2005 - 03/2003
2	Interleukin-17 (Interleukin 17)IBA 01/2013 - 05/2009
2	Small Interfering RNA (siRNA)IBA 01/2013 - 09/2012
2	Amyloid (Amyloid Fibrils)IBA 01/2010 - 04/2008
2	Interleukin-1 (Interleukin 1)IBA 11/2009 - 05/2008
2	Peptide Initiation Factors (Initiation Factor)IBA 10/2009 - 01/2007
2	EpitopesIBA 09/2009 - 10/2007
2	OsteopontinIBA 04/2006 - 11/2004
1	Metalloproteases (Metalloproteinases)IBA 12/2013
1	Minocycline (Cyclops)FDA LinkGeneric 12/2013
1	Prostaglandins EIBA 02/2013
1	Prostaglandin-E SynthasesIBA 02/2013
1	Interleukin-23 (Interleukin 23)IBA 01/2013
1	Interleukin-23 Subunit p19IBA 01/2013
1	Intravenous Immunoglobulins (IVIG)FDA Link 08/2011
1	Biomarkers (Surrogate Marker)IBA 04/2011
1	diacetyldichlorofluoresceinIBA 04/2011
1	AntioxidantsIBA 04/2011
1	SpermidineIBA 04/2011
1	PerforinIBA 10/2010
1	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 06/2010
1	Erythropoietin FDA Link 05/2010
1	HSP27 Heat-Shock ProteinsIBA 12/2009
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 12/2009
1	geranylgeranylacetone (teprenone)IBA 10/2009
1	CurcuminIBA 05/2009
1	Amyloid beta-PeptidesIBA 11/2008
1	Amino Acid Transport System X-AG (Glutamate Transporter)IBA 05/2008
1	4,6- diphenyl- 3- (4- (pyrimidin- 2- yl)piperazin- 1- yl)pyridazineIBA 12/2007
1	Recombinant ProteinsIBA 10/2007
1	LigandsIBA 09/2007
1	Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA 08/2007
1	Interleukin-1alpha (Interleukin 1 alpha)IBA 04/2007
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2007
1	HLA-DPB1*05:01 antigenIBA 01/2007
1	Interferon beta-1b (Betaseron)FDA Link 01/2007
1	B-Lymphocyte Epitopes (B-Cell Epitope)IBA 01/2007
1	Immune Sera (Antisera)IBA 01/2007
1	flotillinsIBA 10/2006
1	CaveolinsIBA 09/2006
1	AutoantigensIBA 08/2006
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 08/2006
1	Immunoglobulins (Immunoglobulin)IBA 08/2006
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 08/2006
1	Cholinergic ReceptorsIBA 04/2006
1	Netrin-1IBA 03/2006
1	p38 Mitogen-Activated Protein KinasesIBA 04/2005
1	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2005

Therapy/Procedure

10	Immunotherapy 01/2015 - 05/2002
8	Therapeutics 12/2013 - 06/2003
2	Oral Administration 10/2009 - 12/2007
1	Transplantation 07/2007